Skip to main content
SpringerLink
Log in

Greatest cost burden for RSV in infants is for those not targeted by prophylaxis strategies

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. ICES is an independent, non-profit health informatics corporation that houses data collected through the routine administration of Ontario's system of publicly-funded healthcare.

  2. 2020 Canadian dollars

Reference

  • Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study. CMAJ Open : 22 Oct 2021. Available from: URL: https://doi.org/10.9778/cmajo.20200219

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greatest cost burden for RSV in infants is for those not targeted by prophylaxis strategies. PharmacoEcon Outcomes News 890, 10 (2021). https://doi.org/10.1007/s40274-021-08133-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08133-z

Search

Navigation